Day 1 of $AVXL closing over the 20 day... can it follow through? We shall see.

Did yesterday's down day change the De Mark flip?

Odd, why can't I see "Investor2014"'s posts? I never had him on ignore?!?

Oh never mind he was just quiet today.

$AVXL gets REJECTED at the 20 day SMA once again. Definitely among the ugliest charts out there right now, but I love her for her brain, not her looks. LOL!!!!

$AVXL is best described as my hobby stock and I have been following the story since 2013.

The markets adjust to the situations at hand and it's the T/A stuff I'm here for from you all. I'm lazy and it's good "office talk" works out well together.

Green trades indeed!

Future commitments have not changed. The P3 PD trial will be done by the Shake it up foundation with MJFF as financial backer. Details from PR below:

https://www.anavex.com/post/anavex-life-sciences-announces-commitment-for-financial-investment-by-shake-it-up-foundation

Also, if truly interested in Anavex read today's SOTC update.

https://www.sotcanalytics.com/update-compendium-2024

I'm sure he means well, but I also see it as just a rich dude using populism for attention.

I think $AVXL floated some stock to keep the coffers full. It sucks, but better than a company like $ANVS's negative equity situation and all hope on the next PD readout. I'm watching that story too.

Dilution is just something I deal with and it's fine in moderation and Missling does whatever he thinks is right and I trust him. Frankly $AVXL isn't spending the money fast enough as I've been expecting a PD trial start to spend it down with help from MJFF for a long time now.

The 20 day average is one stubborn ass level for $AVXL to penetrate...LOL

I generally side with free markets versus populist/socialist type compensation limits, but this a chance for shareholders to voice their opinion on the matter.

I've been on vacation last few weeks, so I'm glad we don't have to wait much longer for the cases to be thrown out. You gave me crap when I said that on day one, but the bickering keeps it entertaining. ;)

Since you've been following, how did the various allegations consolidate to the lead plaintiff part?
Were both RETT and AD included? and what timeframes for the class?

On a side note, I recently added to $AVXL after salvaging what was left of my $ANVS position as my biotech hobby stock list continues to dwindle.
I do wish the $ANVS folks well and hope they can get some financing done with good PD results, but I think heavy dilution will keep their stock price muted.

Agreed, yet I went ahead and added to AVXL for non T/A reasons.

I was trying to be on holiday but the $ANVS AD fail was announced. Which was my primary reason to own, so I sold and put the remainder into $AVXL.
$ANVS does have another shot on on goal with PD, so there may be support for them at $5 and "green trades" to them. But I also know they have a large need to raise funds with equity financing and not sure how well that's going to go unless PD hits.

I'll be curious how the De Mark signal plays out, but also know how conviction plays a part too as Kentucky123 mentioned.

And long time no see 123tom

Yep, the T/A is looking pretty ugly.

$AVXL trying to create a support today if it can string together some green.

Ugly technicals aside, a near term event on my horizon to help create a market cap based support is announcement of the Parkinson's Disease P3 trial start sponsored by MJFF and Shake it Up Foundation Australia.

Correct until a corresponding form 4 is filed the disposition of the stock is unknown, but the tax liability is.

As a fan of technical analysis I'm sure you're pissed at yourself for holding through this trough, the technicals have sucked for quite some time yet you held.

Hang tight, as the science will prevail. As I've mentioned frequently, Anavex is a story stock and the story will soon enter a new positive chapter.

Be well old timers!

Thankfully I have the advantage of riding low basis shares and of being very well off financially, making $AVXL more of a hobby stock to follow for the "story" and science potential. Thus, I have the luxury of time to let the story play out.

Agreed, from a technical standpoint $AVXL is in a very precarious position.

As I've stated before, I'm in $AVXL for the "news" and follow the technicals as a side hobby. I have made various biotech bets in companies that modulate Sigma 1 and muscarinic receptors of which $AVXL is in that group.

There appears to be some signs of support with the first test at the 20 day SMA for $AVXL

IMO it's basically a wee bit of speculative excitement today generated by $ANVS stating their data is cleaned up, and their top line result will be released soon.

The volume was low on $AVXL today so don't give it much weight, but speculative energy in one baby bio often brings speculative energy to them all.

Yep "Us", and on a broader point, it's the unknown that keeps the game interesting, and microcap biotech equity has always been an interesting way to play out ideas.
Biotech....Lets raise some money and say, "Here take this and let's see what happens?" ?!?! LOL!

The case is regarding "alleged violations" of securities laws, plain and simple. The facts will show no securities law were violated.

I do agree who is on the SAB or an employee is immaterial to the case.

Yep, and everyone of these personalities are what makes up the market.

I try to be in the middle and as rational as I can with a risky bet.

I'm in $AVXL for the fear. Risk "IS" the feature in microcap equity, not the drawback.

Them's the breaks in microcap equity.

Being way for awhile, I forgot how far you take the team FUD scare tactic angle. LOL Yeah, hopefully they have good D&O insurance, but more important they paid their premiums right?

Hmmm... $AVXL 6.4 million volume?
I know it was triple witching and some fund families did some rebalancing/reconstitutions, but seems odd.

I'm already of the opinion that crossing session trades are sketch and abusive, but it's a valid trading mechanic. Just need to live it with for now. And while I'm ranting into the void, the next regulatory target should be for more "short disclosure" within the industry.

I see a technical base has been forming too and this time independent of the broader indexes which it a trend change of note.

Hope the 123 regulars have been well.

Regardless it's a distraction and I'll freely admit I'm too lazy, plus as I said In my experience.

One time I think I got a $2 check from Verizon from a class action, plus you can't get blood from a turnip like a microcap biotech. LOL.

Case by case for sure, however, notice this is from "my experience" with the disclaimer "almost", you can provide evidence at your leisure for your point of view.

Regarding the lawsuits, I my experience as a financial compliance manager, I can almost guarantee they all go nowhere thanks to the "forward looking disclaimer" on every corporate communication.

I may have successful real world trading experience, but that definitely doesn't always translate to success with a story stock biotech like $AVXL, as $AVXL remains mostly an educated hunch based on others work on the efficacy of S1R/muscarinic modulation.

My best explanation for todays volume is basically triple witching combined with a couple fund families conducting their index funds rebalancing and reconstitutions, and all the necessary trades were conducted via the NASDAQ closing crossing session. But, that said, today's volume is definitely well out of normal range.

Actually it's not a mess and is a very orderly system that's been in effect for decades. Even before "dark pools", ECN's and all the other trading venues that do create a "mess".

Those of us like myself who did the actual work of trading equities for clients often relied upon the added liquidity of opening and closing crossing sessions to process our largest client orders.

Looks like it's that time again to educate retail on the opening and closing crossing session volumes:

https://nasdaqtrader.com/content/productsservices/trading/crosses/openclose_faqs.pdf

$AVXL is helped today by the broader indexes for a bullish sentiment. But I disagree that this is a "pivotal week" or the need for news or "answers". Why this week I your opinion?

I've noticed retails shareholders are getting quite anxious for AD news to drop. In addition to AD, I'm expecting some updates on PD trials to start in Australia. It might not move the market, but something I'm watching for.

Hold the line!

I've got covered calls expiring tomorrow. Looking for a market driven sign or signal on when and at what levels of time and strike to pull the trigger to bet on a positive reaction to peer reviewed paper publishing.

How's that for a run on sentence!

Maybe someday the rules of "should be updated" will be changed to required to be updated.

Unfortunately there are many under updated pages in that database. Not an excuse for Anavex, but they are simply doing as their non-government funded peers do.

Indeed the same biotech company where for the low, low price of $5.75 you too can get in on the ground floor of a company that some say has "an absolutely certain 85% chance of EMA approval for their drug in AD."

Who knows maybe it will be a $6 stock again too?

Also of note, $AVXL stabilized after volume event in resistance to broader market headwinds.

I would expect price support in this area and had $5.75 as a low to watch for holding.

Nice volatility or $6 remains the battleground. I had ~5.75 as an exhaustion point if tested and met, we'll see....

The trial was successful, "Missling also stressed this point in his JPM 2024 presentation" "